i-SENS, Inc.

KOSDAQ:A099190 Stock Report

Market Cap: ₩529.5b

i-SENS Valuation

Is A099190 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of A099190 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: A099190 (₩19160) is trading above our estimate of fair value (₩2206.86)

Significantly Below Fair Value: A099190 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A099190?

Key metric: As A099190 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for A099190. This is calculated by dividing A099190's market cap by their current revenue.
What is A099190's PS Ratio?
PS Ratio1.9x
Sales₩280.29b
Market Cap₩529.47b

Price to Sales Ratio vs Peers

How does A099190's PS Ratio compare to its peers?

The above table shows the PS ratio for A099190 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.8x
A145720 Dentium
1.2x11.5%₩482.9b
A336570 WON TECHLtd
3.7x33.4%₩399.8b
A043150 Value Added Technology
0.8x8.5%₩301.5b
A041830 InBodyLtd
1.6x11.2%₩291.8b
A099190 i-SENS
1.9x17.1%₩529.5b

Price-To-Sales vs Peers: A099190 is expensive based on its Price-To-Sales Ratio (1.9x) compared to the peer average (1.8x).

Price to Sales Ratio vs Industry

How does A099190's PS Ratio compare vs other companies in the KR Medical Equipment Industry?

4 CompaniesPrice / SalesEstimated GrowthMarket Cap
A008490 Suheung
0.2x6.9%US$105.73m
A263690 DRGEM
0.6xn/aUS$44.96m
A083550 KM
0.3xn/aUS$24.61m
A043100 AlphanoxLtd
0.6xn/aUS$11.48m
No more companies available in this PS range
A099190 1.9xIndustry Avg. 2.1xNo. of Companies16PS02.44.87.29.612+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: A099190 is good value based on its Price-To-Sales Ratio (1.9x) compared to the KR Medical Equipment industry average (2.1x).

Price to Sales Ratio vs Fair Ratio

What is A099190's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A099190 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.9x
Fair PS Ratio2.1x

Price-To-Sales vs Fair Ratio: A099190 is good value based on its Price-To-Sales Ratio (1.9x) compared to the estimated Fair Price-To-Sales Ratio (2.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst A099190 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₩19,160.00
₩33,000.00
+72.2%
15.2%₩38,000.00₩28,000.00n/a2
Nov ’25₩18,580.00
₩34,000.00
+83.0%
11.8%₩38,000.00₩30,000.00n/a2
Oct ’25₩17,410.00
₩34,000.00
+95.3%
11.8%₩38,000.00₩30,000.00n/a2
Sep ’25₩16,720.00
₩34,000.00
+103.3%
11.8%₩38,000.00₩30,000.00n/a2
Aug ’25₩18,960.00
₩34,000.00
+79.3%
11.8%₩38,000.00₩30,000.00n/a2
Jul ’25₩20,050.00
₩34,750.00
+73.3%
9.4%₩38,000.00₩31,500.00n/a2
Jun ’25₩17,620.00
₩34,750.00
+97.2%
9.4%₩38,000.00₩31,500.00n/a2
May ’25₩19,630.00
₩31,750.00
+61.7%
0.8%₩32,000.00₩31,500.00n/a2
Apr ’25₩21,250.00
₩31,750.00
+49.4%
0.8%₩32,000.00₩31,500.00n/a2
Mar ’25₩22,950.00
₩31,750.00
+38.3%
0.8%₩32,000.00₩31,500.00n/a2
Feb ’25₩23,750.00
₩34,750.00
+46.3%
9.4%₩38,000.00₩31,500.00n/a2
Jan ’25₩28,600.00
₩32,250.00
+12.8%
2.3%₩33,000.00₩31,500.00n/a2
Dec ’24₩22,900.00
₩32,250.00
+40.8%
2.3%₩33,000.00₩31,500.00n/a2
Nov ’24₩23,850.00
₩29,000.00
+21.6%
27.6%₩37,000.00₩21,000.00₩18,580.002
Oct ’24₩26,950.00
₩29,000.00
+7.6%
27.6%₩37,000.00₩21,000.00₩17,410.002
Sep ’24₩31,300.00
₩29,000.00
-7.3%
27.6%₩37,000.00₩21,000.00₩16,720.002
Aug ’24₩31,700.00
₩27,500.00
-13.2%
23.6%₩34,000.00₩21,000.00₩18,960.002

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

Ray

₩100.3b

RAY Co., Ltd. provides x-ray diagnostic equipment in the dental industry.

A228670

₩6,470.00

7D

-0.3%

1Y

-73.4%

Vieworks

₩200.2b

Develops, manufactures, and sells imaging systems and solutions.

A100120

₩21,800.00

7D

6.3%

1Y

-19.1%

Boditech Med

₩347.2b

Offers instruments and diagnostic reagents in South Korea and internationally.

A206640

₩15,800.00

7D

0.1%

1Y

-10.4%